News Sarepta announces Allergan veteran as next CEO Sarepta has announced former Allergan president Doug Ingram will be its new CEO.
News More good news for Bluebird Bio with CALD gene therapy Bluebird Bio has presented encouraging data from its gene therapy treatment for t
News UK patients gain early access to Duchenne drug Patients to get Santhera's Raxone under EAMS scheme.
News Neuralink unveils trial linking brain implant to robotic arm Neuralink has been given regulatory approval to start a new trial of its brain implant to see if it can be used to control a robotic arm
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
